Oxalate Absorption Blocking Composition for Kidney Stone Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Individuals on vegetable-centric and raw food diets may experience increased oxalate absorption, leading to health issues such as fibromyalgia pain, kidney stones, and calcification of the spine and shoulder, for which existing solutions either limit healthy food consumption or fail to effectively reduce oxalate absorption.
Innovation Solution
An oxalate absorption blocking (OAB) composition comprising calcium, magnesium, and probiotics, such as Oxalobacter formigenes, is orally administered to reduce oxalate absorption from food, with a therapeutically effective amount of 100 mg to 2500 mg of calcium and 50 mg to 1500 mg of magnesium, and can include carbonate, vitamins, and analgesics, to inhibit oxalate absorption and alleviate associated pain.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If individuals consume more vegetable-centric and raw food diets rich in oxalate, then health improves in certain ways, but oxalate absorption increases leading to health complications
Solution Approach 1:
The patent introduces calcium and magnesium as intermediary substances that bind to oxalate in the gastrointestinal tract, forming insoluble complexes that prevent oxalate absorption. This mediator approach allows individuals to continue consuming oxalate-rich foods while blocking the harmful absorption pathway through the addition of calcium/magnesium supplements or fortified foods.
Solution Approach 2:
The patent converts the potentially harmful effect of oxalate into a beneficial outcome by having calcium and magnesium bind to oxalate to form insoluble precipitates. This transformation turns the harmful oxalate absorption process into a beneficial excretion process, where the oxalate-calcium/magnesium complex is eliminated in feces rather than absorbed into the body.
2Object-affected harmful factors
If individuals limit consumption of oxalate-rich foods to reduce oxalate absorption, then health complications decrease, but consumption of healthy foods is reduced
Solution Approach 1:
Rather than removing oxalate-rich foods from the diet, the patent introduces calcium and magnesium as intermediary substances that selectively bind to oxalate. This allows the full quantity of healthy oxalate-rich foods to be consumed while the harmful oxalate component is neutralized by the calcium/magnesium mediator, forming excretable complexes.
Solution Approach 2:
The patent segments the oxalate molecule from its beneficial food matrix by having calcium/magnesium bind specifically to the oxalate component. This segmentation allows the beneficial aspects of oxalate-rich foods to be retained while isolating and removing the harmful oxalate portion through selective binding and excretion.
3Object-affected harmful factors
If calcium and magnesium are administered to block oxalate absorption, then oxalate absorption decreases, but the composition complexity increases
Solution Approach 1:
The patent optimizes the calcium-to-magnesium ratio parameter in the composition to achieve effective oxalate blocking while minimizing composition complexity. By establishing specific ratio ranges (such as 2:1 to 10:1 calcium to magnesium), the patent simplifies the formulation process and manufacturing while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent creates a composite material system combining calcium compounds, magnesium compounds, and optionally probiotics in specific ratios. This composite approach consolidates multiple functional ingredients into a single integrated composition that works synergistically to block oxalate absorption, simplifying administration compared to taking multiple separate supplements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The OAB composition effectively reduces oxalate absorption and associated pain by promoting healthy intestinal flora, allowing individuals to consume oxalate-rich foods without negative health effects, thereby improving overall health and reducing symptoms of hyperoxaluria, kidney stones, and other conditions.
Implementation Method 1
The OAB composition may include compounds such as calcium carbonate and/or magnesium carbonate... The oral administration of the OAB composition may decrease the amount of oxalate absorbed, by the body of an individual, from foods consumed by the individual
Implementation Method 2
The oxalate absorption blocking composition comprises one or more probiotics. The oxalate absorption blocking composition comprises Oxalobacter formigenes
Data Source
Figure 1
AI summary
In various implementations, an oxalate absorption blocking (OAB) composition may be administered to improve a health of an individual. The OAB composition may include calcium and/or magnesium. In some implementations, the OAB composition may include one or more carbonates, probiotics, vitamins and/or other minerals. A therapeutically effective amount of the OAB composition may be administered to reduce oxalate absorption from foods consumed by an individual. Reducing oxalate absorption from foods consumed by an individual may decrease pain, improve movement of joints, inhibit kidney stone formation, and/or otherwise improve an individual's health.